tradingkey.logo

Treace Medical Concepts Inc

TMCI
2.420USD
-0.020-0.82%
收盤 12/26, 16:00美東報價延遲15分鐘
154.17M總市值
虧損本益比TTM

Treace Medical Concepts Inc

2.420
-0.020-0.82%

關於 Treace Medical Concepts Inc 公司

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

Treace Medical Concepts Inc簡介

公司代碼TMCI
公司名稱Treace Medical Concepts Inc
上市日期Apr 23, 2021
CEOTreace (John T)
員工數量477
證券類型Ordinary Share
年結日Apr 23
公司地址100 Palmetto Park Place
城市PONTE VEDRA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編32081
電話19043735940
網址https://www.treace.com/
公司代碼TMCI
上市日期Apr 23, 2021
CEOTreace (John T)

Treace Medical Concepts Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ms. Elizabeth S. (Betsy) Hanna
Ms. Elizabeth S. (Betsy) Hanna
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月25日 週二
更新時間: 11月25日 週二
持股股東
股東類型
持股股東
持股股東
佔比
Treace (John T.)
18.37%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.29%
其他
56.62%
持股股東
持股股東
佔比
Treace (John T.)
18.37%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.29%
其他
56.62%
股東類型
持股股東
佔比
Individual Investor
25.43%
Investment Advisor/Hedge Fund
23.25%
Hedge Fund
18.89%
Investment Advisor
16.47%
Research Firm
2.22%
Bank and Trust
0.31%
Pension Fund
0.04%
Family Office
0.03%
Insurance Company
0.03%
其他
13.33%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
338
38.30M
60.11%
-18.99M
2025Q2
369
55.28M
87.88%
-20.58M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
2023Q2
290
57.64M
94.33%
-3.44M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Treace (John T.)
11.70M
18.53%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.26M
9.91%
+49.00K
+0.79%
Jun 30, 2025
William Blair Investment Management, LLC
3.10M
4.91%
+39.28K
+1.28%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.28M
5.2%
-119.04K
-3.50%
Jun 30, 2025
The Vanguard Group, Inc.
2.73M
4.31%
+20.22K
+0.75%
Jun 30, 2025
Gagnon Securities LLC
2.25M
3.56%
-459.82K
-16.97%
Jun 30, 2025
Treace (James T)
1.78M
2.82%
--
--
Mar 24, 2025
Millennium Management LLC
1.52M
2.4%
+1.07M
+241.03%
Jun 30, 2025
CIBC Private Wealth Management
1.69M
2.67%
-606.00K
-26.42%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
908.03K
1.44%
+409.11K
+82.00%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares U.S. Medical Devices ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Fidelity Enhanced Small Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Morningstar Small-Cap ETF
0%
查看更多
iShares U.S. Medical Devices ETF
佔比0.04%
Franklin US Small Cap Multifactor Index ETF
佔比0.04%
iShares Russell 2000 Growth ETF
佔比0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.01%
Schwab U.S. Small-Cap ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
Fidelity Enhanced Small Cap ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
iShares Morningstar Small-Cap ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Treace Medical Concepts Inc的前五大股東是誰?

Treace Medical Concepts Inc的前五大股東如下:
Treace (John T.)
持有股份:11.70M
佔總股份比例:18.53%。
Armistice Capital LLC
持有股份:6.26M
佔總股份比例:9.91%。
William Blair Investment Management, LLC
持有股份:3.10M
佔總股份比例:4.91%。
BlackRock Institutional Trust Company, N.A.
持有股份:3.28M
佔總股份比例:5.20%。
The Vanguard Group, Inc.
持有股份:2.73M
佔總股份比例:4.31%。

Treace Medical Concepts Inc的前三大股東類型是什麼?

Treace Medical Concepts Inc 的前三大股東類型分別是:
Treace (John T.)
Armistice Capital LLC
William Blair Investment Management, LLC

有多少機構持有Treace Medical Concepts Inc(TMCI)的股份?

截至2025Q3,共有338家機構持有Treace Medical Concepts Inc的股份,合計持有的股份價值約為38.30M,占公司總股份的60.11% 。與2025Q2相比,機構持股有所增加,增幅為-27.77%。

哪個業務部門對Treace Medical Concepts Inc的收入貢獻最大?

在--,--業務部門對Treace Medical Concepts Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI